Anti-Phospholamban (phospho S16) antibody [EPR1911]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal Phospholamban phospho S16 antibody. Suitable for WB and reacts with Human samples. Cited in 4 publications.
View Alternative Names
PLB, PLN, Phospholamban
- WB
Unknown
Western blot - Anti-Phospholamban (phospho S16) antibody [EPR1911] (AB92697)
Actual band size is 11 KDa.
All lanes:
Western blot - Anti-Phospholamban (phospho S16) antibody [EPR1911] (ab92697) at 1/200000 dilution
Lane 1:
Fetal heart lysate (untreated) at 10 µg
Lane 2:
Fetal heart lysate (treated with LP) at 10 µg
Secondary
All lanes:
HRP labelled Goat anti-Rabbit antibody at 1/2000 dilution
Predicted band size: 6 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Properties and storage information
Form
Purity
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Phospholamban serves as an important mediator in the control of cardiac muscle contraction and relaxation. It is a component of the calcium cycling process within heart cells and associates directly with SERCA2a to form a regulatory complex. This association allows phospholamban to influence calcium homeostasis significantly affecting myocardial contractility and relaxation. Phosphorylation of phospholamban typically induced by beta-adrenergic signaling results in diminished interaction with SERCA2a enhancing calcium uptake into the sarcoplasmic reticulum.
Pathways
Several important pathways involve phospholamban including the adrenergic signaling pathway in cardiomyocytes and calcium signaling pathways. Phospholamban's role in these pathways is linked with proteins like SERCA2a and Protein Kinase A (PKA). PKA phosphorylates phospholamban an important step in the beta-adrenergic cascade that leads to increased heart muscle contractility. This phosphorylation event highlights phospholamban's participation in modulating cardiac output under sympathetic nervous system influence.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Acupuncture in medicine : journal of the British Medical Acupuncture Society 42:342-355 PubMed39579035
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports methods 3:100456 PubMed37159667
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular and cellular biochemistry 476:3079-3087 PubMed33811579
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 9:1383 PubMed30356673
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com